Eli Lilly is just weeks away from launching Mounjaro in the UK, after getting approval from medicines regulator, the MHRA, for a new formulation of the drug as a treatment
The UK medicines regulator has launched its mutual recognition framework for authorising medicines in a move that it says will help to bring new drugs to patients in the U
In a firmly post-pandemic world, regulators such as the Medicines and Healthcare products Regulatory Agency (MHRA) have increased the frequency and depth of in-person inspections of pharmac
The first-ever CRISPR-based gene-editing therapy has been approved for marketing in the UK for inherited blood disorders sickle cell disease (SCD) and transfusion-dependen
Professor Andrea Manfrin joined the MHRA in June 2023 as Deputy Director of Clinical Investigations and Trials, to spearhead the regulator’s overhaul of the clinical trial regulations.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
